PROFOUND MEDICAL CORP
TSX
CA Flag
PRN

PRN
PROFOUND MEDICAL CORP
CA Flag
TSX
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

PRN Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Employees: ---
Profound Medical Corp., formerly Mira IV Acquisition Corp., is a capital pool company. The Company is a medical device company focused on prostate cancer care. Its product consists of common electronic components, capital equipment and disposables. The Company is developing and commercializing a minimally invasive procedure for patients with prostate cancer, the Transurethral Ultrasound Ablation-PRO (TULSA-PRO) system. Its technology combines magnetic resonance imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland delivered through the urethra. Its real-time, MRI guided ultrasound procedure (TULSA) ablates the whole prostate gland, from the inside out, in a single session. It has completed a Phase l International Clinical Trial. The Phase I trial has demonstrated that magnetic resonance (MR)-guided TULSA provides treatment planning, real-time thermal dosimetry and control of prostate ablation to within approximately 1.3 millimeters.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Get Help Ideas Published Followers Following Private Messages Chat Sign Out